Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol
Authors
Keywords
Biofilms, Candida albicans, Antimicrobial resistance, Candida, Antifungals, Glucose, MTT assay, Drug metabolism
Journal
PLoS One
Volume 15, Issue 5, Pages e0233102
Publisher
Public Library of Science (PLoS)
Online
2020-05-12
DOI
10.1371/journal.pone.0233102
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Candida auris Isolates Resistant to Three Classes of Antifungal Medications — New York, 2019
- (2020) Belinda Ostrowsky et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Candida auris - the growing menace to global health
- (2019) Shabir Ahmad Lone et al. MYCOSES
- Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of Candida albicans
- (2019) Lucia Černáková et al. Microbial Drug Resistance
- Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris
- (2019) Jeffrey M. Rybak et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Fungicidal action of geraniol against Candida albicans is potentiated by abrogated CaCdr1p drug efflux and fluconazole synergism
- (2018) Shweta Singh et al. PLoS One
- The possible molecular mechanisms of farnesol on the antifungal resistance of C. albicans biofilms: the regulation of CYR1 and PDE2
- (2018) Shengyan Chen et al. BMC MICROBIOLOGY
- The comparative efficacy of antiseptics against Candida auris biofilms
- (2018) Ryan Kean et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Notes from the Field: Ongoing Transmission of Candida auris in Health Care Facilities — United States, June 2016–May 2017
- (2017) Sharon Tsay et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Current perspective on emergence, diagnosis and drug resistance in Candida auris
- (2017) Smita Sarma et al. Infection and Drug Resistance
- Simultaneous Emergence of Multidrug-ResistantCandida aurison 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
- (2016) Shawn R. Lockhart et al. CLINICAL INFECTIOUS DISEASES
- Anti-biofilm activity of the metabolites of Streptomyces chrestomyceticus strain ADP4 against Candida albicans
- (2016) Vartika Srivastava et al. JOURNAL OF BIOSCIENCE AND BIOENGINEERING
- First report of Candida auris in America: Clinical and microbiological aspects of 18 episodes of candidemia
- (2016) Belinda Calvo et al. JOURNAL OF INFECTION
- Synergistic Effect of Fluconazole and Calcium Channel Blockers against Resistant Candida albicans
- (2016) Shuyuan Liu et al. PLoS One
- Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method
- (2015) Shallu Kathuria et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Saccharomyces cerevisiae biofilm tolerance towards systemic antifungals depends on growth phase
- (2014) Rasmus Bojsen et al. BMC MICROBIOLOGY
- Incidence, characteristics and outcome of ICU-acquired candidemia in India
- (2014) Arunaloke Chakrabarti et al. INTENSIVE CARE MEDICINE
- Efflux pump proteins in antifungal resistance
- (2014) Rajendra Prasad et al. Frontiers in Pharmacology
- Reversal of efflux mediated antifungal resistance underlies synergistic activity of two monoterpenes with fluconazole
- (2012) Aijaz Ahmad et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The metabolic response ofCandida albicansto farnesol under hyphae-inducing conditions
- (2012) Ting-Li Han et al. FEMS YEAST RESEARCH
- Possible Inhibitory Molecular Mechanism of Farnesol on the Development of Fluconazole Resistance in Candida albicans Biofilm
- (2011) Li-hua Yu et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Quorum-Sensing Molecule Farnesol Is a Modulator of Drug Efflux Mediated by ABC Multidrug Transporters and Synergizes with Drugs in Candida albicans
- (2011) Monika Sharma et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- First Three Reported Cases of Nosocomial Fungemia Caused by Candida auris
- (2011) Wee Gyo Lee et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Farnesol Induces Hydrogen Peroxide Resistance in Candida albicans Yeast by Inhibiting the Ras-Cyclic AMP Signaling Pathway
- (2010) Aurélie Deveau et al. EUKARYOTIC CELL
- Activity and Toxicity of Farnesol towards Candida albicans Are Dependent on Growth Conditions
- (2009) M. L. Langford et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Farnesol-Induced Apoptosis in Candida albicans
- (2009) M. E. Shirtliff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Cellular interactions of farnesol, a quorum-sensing molecule produced byCandida albicans
- (2009) Melanie L Langford et al. Future Microbiology
- Candida aurissp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital
- (2009) Kazuo Satoh et al. MICROBIOLOGY AND IMMUNOLOGY
- In vitro growth and analysis of Candida biofilms
- (2008) Jyotsna Chandra et al. Nature Protocols
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started